Which hedge funds own ARWR? ARROWHEAD PHARMACEUTICALS IN, Q2 2026 13F holders
63 tracked hedge funds disclosed a position in ARWR (ARROWHEAD PHARMACEUTICALS IN) in their Q2 2026 13F filings, worth $1.9bn in total. The largest holder by portfolio weight is Avoro Capital Advisors LLC at 8.3% of its book. 25 opened a new position this quarter: Stempoint Capital LP, Catalyst Funds Management Pty Ltd, Ikarian Capital, LLC, Polymer Capital Management (HK) LTD. 21 exited: Ishara Investments LP, Ares Systematic Credit Ltd, RTW Investments, LP.
- 63
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 25
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 21
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $194m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $77.4m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $1.9bn
- Combined value Sum of the holders' reported positions in the security.
- 5.1%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Ishara Investments LP | 3.5% | $3.5m |
| Ares Systematic Credit Ltd | 0.6% | $759k |
| RTW Investments, LP | 0.4% | $36.7m |
| PDT Partners, LLC | 0.3% | $4.4m |
| Cinctive Capital Management LP | 0.2% | $3.1m |
| Aquatic Capital Management LLC | 0.1% | $5.0m |
| EntryPoint Capital, LLC | 0.1% | $454k |
| J. Goldman & Co LP | 0.1% | $2.6m |
| FORA Capital, LLC | 0.1% | $1.5m |
| Quarry LP | 0.09% | $423k |
| Prelude Capital Management, LLC | 0.07% | $954k |
| Soleus Capital Management, L.P. | 0.07% | $1.8m |
| Campbell & CO Investment Adviser LLC | 0.07% | $1.2m |
| Gsa Capital Partners LLP | 0.03% | $556k |
| Seven Grand Managers, LLC | 0.03% | $470k |
| Entropy Technologies, LP | 0.03% | $666k |
| Bridgewater Associates, LP | 0.03% | $6.0m |
| Mangrove Partners IM, LLC | 0.02% | $238k |
| Farallon Capital Management, L.L.C. | 0.01% | $991k |
| Citadel Advisors LLC | 0.0% | $6.2m |
| Elequin Capital, LP | 0.0% | $3.7k |
Ownership over time
Who discovered ARWR first? Beta
The run: Q2 2017 → Q4 2019, ×39
| RTW Investments, LP high conviction | Q2 2018 | – | +5.8 pts |
| M28 Capital Management LP high conviction | Q4 2022 | – | +3.6 pts |
| First Light Asset Management, LLC | Q4 2020 | – | +1.0 pts |
| Rokos Capital Management LLP | Q1 2023 | – | +0.9 pts |
| Prosight Management, LP | Q1 2020 | – | +0.7 pts |
| Parkman Healthcare Partners LLC | Q4 2020 | – | +0.2 pts |
| Commodore Capital LP | Q2 2022 | – | +0.2 pts |
| Avidity Partners Management LP | Q3 2021 | – | −0.5 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.